Polaris Group
TWSE:6550

Watchlist Manager
Polaris Group Logo
Polaris Group
TWSE:6550
Watchlist
Price: 50.3 TWD 0.6% Market Closed
Market Cap: 37.5B TWD
Have any thoughts about
Polaris Group?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-18.7
Current
-57.9
Median
4.7
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-18.7
=
Enterprise Value
34.5B TWD
/
EBITDA
-1.8B TWD
All Countries
Close
EBITDA Growth
KY
Polaris Group
TWSE:6550
Average EV/EBITDA: 49.7
Negative Multiple: -18.7
N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
19.5
64%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
37%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
22.3
53%
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
9%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.4 N/A
AU
CSL Ltd
ASX:CSL
22.5
42%
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
230.2
N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -35.6 N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More